Molecular mechanisms of target recognition in an innate immune system: Interactions among factor H, C3b, and target in the alternative pathway of human complement

被引:96
作者
Pangburn, MK
Pangburn, KLW
Koistinen, V
Meri, S
Sharma, AK
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Biochem, Tyler, TX 75708 USA
[2] Univ Helsinki, Haartman Inst, Complement Res Unit, Helsinki, Finland
关键词
D O I
10.4049/jimmunol.164.9.4742
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the alternative pathway of complement (APC) factor H is the primary control factor involved in discrimination between potential pathogens. The APC deposits C3b on possible Ags, and the interaction with factor Il determines whether the initial C3b activates the APC. Factor H is composed of a linear array of 20 homologous short consensus repeats (SCR) domains with many functional sites. Three of these sites are involved in binding C3b and regulating complement activation; others bind to sialic acid and/or heparin and are responsible for host recognition. Using site-directed mutations we have examined the contributions of each of these sites to target discrimination and to functional activities of factor H. Decay acceleration by SCR1-4 of C3/C5 convertases bound to nonactivators was strongly dependent on SCR domains 11-15 and 16-20, Loss of these regions caused a 97% loss of activity, with SCR16-20 being the most critical (>90% loss). On APC activators the pattern of site usage was different and unique on each. On yeast, deletion of the 10 C-terminal domains (SCR11-20) had no effect on specific activity. On rabbit erythrocytes, this deletion caused loss of 75% of the specific activity. An examination of binding affinity to C3b on the four cell types demonstrated that factor H exhibits a unique pattern of SCR involvement on each cell. The results reveal a complex molecular mechanism of discrimination between microbes and host in this ancient innate defense system and help explain the different rates and intensities of APC activation on different biological particles.
引用
收藏
页码:4742 / 4751
页数:10
相关论文
共 74 条
[1]   LOCALIZATION OF THE COMPLEMENT-COMPONENT-C3B-BINDING SITE AND THE COFACTOR ACTIVITY FOR FACTOR-I IN THE 38KDA TRYPTIC FRAGMENT OF FACTOR-H [J].
ALSENZ, J ;
LAMBRIS, JD ;
SCHULZ, TF ;
DIERICH, MP .
BIOCHEMICAL JOURNAL, 1984, 224 (02) :389-398
[2]   STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE COMPLEMENT COMPONENT FACTOR-H WITH THE USE OF DIFFERENT ENZYMES AND MONOCLONAL-ANTIBODIES TO FACTOR-H [J].
ALSENZ, J ;
SCHULZ, TF ;
LAMBRIS, JD ;
SIM, RB ;
DIERICH, MP .
BIOCHEMICAL JOURNAL, 1985, 232 (03) :841-850
[3]  
[Anonymous], NATURE
[4]  
ATKINSON J P, 1991, Clinical and Experimental Immunology, V86, P27
[5]  
BLACKMORE T, 1996, MOL IMMUNOL, V33, P15
[6]   REGULATION OF THE HUMAN ALTERNATIVE COMPLEMENT PATHWAY - FORMATION OF A TERNARY COMPLEX BETWEEN FACTOR-H, SURFACE-BOUND C3B AND CHEMICAL GROUPS ON NONACTIVATING SURFACES [J].
CARRENO, MP ;
LABARRE, D ;
MAILLET, F ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (11) :2145-2150
[7]   The role of complement and complement receptors in induction and regulation of immunity [J].
Carroll, MC .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :545-568
[8]  
CHRISTOPHERSON RI, 1983, METHOD ENZYMOL, V91, P278
[9]   COMPLEMENT EVASION STRATEGIES OF MICROORGANISMS [J].
COOPER, NR .
IMMUNOLOGY TODAY, 1991, 12 (09) :327-331
[10]  
DEVINE D V, 1991, Transfusion Medicine Reviews, V5, P123, DOI 10.1016/S0887-7963(91)70199-5